Jubilant Pharmova Ltd reports Q2 FY27 revenue of ₹2,370 crore, up 20.5% year on year, and net profit of ₹31 crore
- Revenue rose 6.3% sequentially; calculated EBITDA margin was approximately 10.1%.
- Net profit declined 45.0% sequentially and 74.1% year on year.
- Results included a ₹5.8 crore exceptional item; auditor’s limited review was unmodified.